Marion Subklewe

Prof. Marion Subklewe is a Professor for Internal Medicine with a focus on Cellular Immunotherapy at LMU Munich's University Hospital, leading the Laboratory for Translational Cancer Immunology at the Gene Center Munich. She holds roles as Head of the Clinical Cooperation Group 'Immunotherapy' and has extensive experience in hematology/oncology research and clinical practice. Her work spans translational cancer immunology, targeting leukemias and lymphomas through novel therapies like bispecific antibodies and CAR T-cells.

Education includes a Medical Degree (1995) and Habilitation (2007) from the Universities of Cologne and Charité Berlin. Awards highlight her contributions to immunotherapy and clinical research. She leads the Else Kröner Clinician Scientist Program in Cancer Immunotherapy and chairs multiple clinical trials (e.g., Phase I/II trials for AML treatments).

Research collaborations include the Bavarian Immunotherapy Network, Helmholtz Alliance, and Munich Immunotherapy Consortium. She actively reviews grants for DFG, Deutsche Krebshilfe, and international bodies. Professional memberships span societies like ASH, EHA, and SITC.